114 related articles for article (PubMed ID: 30478638)
21. Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population.
Crane MM; Juneja M; Allen J; Kurrasch RH; Chu ME; Quattrocchi E; Manson SC; Chang DJ
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1646-55. PubMed ID: 26097059
[TBL] [Abstract][Full Text] [Related]
22. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective.
Widdifield J; Bernatsky S; Paterson JM; Thorne JC; Cividino A; Pope J; Gunraj N; Bombardier C
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):53-7. PubMed ID: 20806274
[TBL] [Abstract][Full Text] [Related]
23. Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
[TBL] [Abstract][Full Text] [Related]
24. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS
Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
[TBL] [Abstract][Full Text] [Related]
25. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.
Katchamart W; Narongroeknawin P; Chevaisrakul P; Dechanuwong P; Mahakkanukrauh A; Kasitanon N; Pakchotanon R; Sumethkul K; Ueareewongsa P; Ukritchon S; Bhurihirun T; Duangkum K; Intapiboon P; Intongkam S; Jangsombatsiri W; Jatuworapruk K; Kositpesat N; Leungroongroj P; Lomarat W; Petcharat C; Sittivutworapant S; Suebmee P; Tantayakom P; Tipsing W; Asavatanabodee P; Chiowchanwisawakit P; Foocharoen C; Koolvisoot A; Louthrenoo W; Siripaitoon B; Totemchokchyakarn K; Kitumnuaypong T;
Int J Rheum Dis; 2017 Sep; 20(9):1142-1165. PubMed ID: 27452207
[TBL] [Abstract][Full Text] [Related]
27. Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.
Sparks JA; Krumme AA; Shrank WH; Matlin OS; Brill G; Pezalla EJ; Choudhry NK; Solomon DH
Arthritis Rheumatol; 2016 Jul; 68(7):1588-95. PubMed ID: 26866506
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic approaches of general practitioners and rheumatologists in South Germany in rheumatoid arthritis and gonarthrosis].
Günaydin I; Maleitzke R; Göttl KH; Tschirdewahn B
Z Rheumatol; 1997; 56(2):80-8. PubMed ID: 9235814
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with use of disease modifying agents for rheumatoid arthritis in the National Hospital and Ambulatory Medical Care Survey.
Gaitonde P; Bozzi LM; Shaya FT
Semin Arthritis Rheum; 2018 Apr; 47(5):649-653. PubMed ID: 29153870
[TBL] [Abstract][Full Text] [Related]
30. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
31. Pain, depressive symptoms and medication in German patients with rheumatoid arthritis-results from the linking patient-reported outcomes with claims data for health services research in rheumatology (PROCLAIR) study.
Jobski K; Luque Ramos A; Albrecht K; Hoffmann F
Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):766-774. PubMed ID: 28345245
[TBL] [Abstract][Full Text] [Related]
32. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
Khanna R; Smith MJ
Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
[TBL] [Abstract][Full Text] [Related]
33. [Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg].
Strahl A; Schneider O; Frankenhauser-Mannuß J; Knapstein S; Hermann C; Lembeck B; Lorenz HM; Rüther W; Flechtenmacher J
Z Rheumatol; 2018 Mar; 77(2):113-126. PubMed ID: 28929232
[TBL] [Abstract][Full Text] [Related]
34. [Prescription frequency of physical therapy and analgesics before total hip and knee arthroplasy : An epidemiological analysis of routine health care data from Germany].
Lange T; Luque Ramos A; Albrecht K; Günther KP; Jacobs H; Schmitt J; Hoffmann F; Goronzy J; Postler A
Orthopade; 2018 Dec; 47(12):1018-1026. PubMed ID: 30171290
[TBL] [Abstract][Full Text] [Related]
35. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
[TBL] [Abstract][Full Text] [Related]
36. Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population.
Shipton D; Glazier RH; Guan J; Badley EM
Med Care; 2004 Sep; 42(9):907-13. PubMed ID: 15319617
[TBL] [Abstract][Full Text] [Related]
37. Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross-sectional patient-reported survey data.
Callhoff J; Albrecht K; Marschall U; Strangfeld A; Hoffmann F
Pharmacoepidemiol Drug Saf; 2023 May; 32(5):517-525. PubMed ID: 36349482
[TBL] [Abstract][Full Text] [Related]
38. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
39. Patterns of drug use in rheumatoid arthritis.
Bérard A; Solomon DH; Avorn J
J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
[TBL] [Abstract][Full Text] [Related]
40. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
Nanji JA; Choi M; Ferrari R; Lyddell C; Russell AS
J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
